Nutriband Inc. (NASDAQ: NTRB), a company developing a portfolio of transdermal pharmaceutical products, has confirmed that its outstanding warrants will expire as scheduled on September 30, 2026, at 5 p.m. EDT, with no extension or repricing. The announcement provides clarity for warrant holders and investors, as the company has chosen not to alter the terms of the warrants, which carry a strike price of $6.43 per share.
According to the company, 910,904 warrants are currently outstanding. If all warrants are exercised at the $6.43 strike price before expiration, Nutriband could receive approximately $5.86 million in potential proceeds. After the expiration date, any unexercised warrants will expire in their entirety and be removed from the NTRBW Nasdaq listing. This means warrant holders who fail to act by the deadline will forfeit their right to purchase shares at the set price.
The decision to let the warrants expire on schedule, rather than extending or repricing them, underscores Nutriband’s confidence in its current capital structure and strategic direction. For a development-stage pharmaceutical company, maintaining a clear and predictable equity structure is important for investor relations and future financing efforts. The potential influx of $5.86 million, if realized, could support ongoing research and development, including the company’s lead product under development, an abuse-deterrent fentanyl patch incorporating its AVERSA(TM) abuse-deterrent technology.
AVERSA(TM) technology is designed to be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. Given the ongoing opioid crisis, technologies that deter abuse of potent pain medications like fentanyl are of significant public health interest. Nutriband’s focus on this area positions it within a niche but critical segment of the pharmaceutical industry.
Warrant holders are reminded that they may exercise their warrants at the current strike price of $6.43 per share until the expiration date. The company’s decision not to extend or reprice the warrants means that the terms are final. Investors seeking more details can view the full press release at https://nnw.fm/5DRKN. Additional information about Nutriband is available on the company’s website at www.nutriband.com, and the latest news and updates relating to NTRB can be found in the company’s newsroom at https://nnw.fm/NTRB.
The announcement was distributed through NetworkNewsWire, a specialized communications platform focused on financial news and content distribution. NetworkNewsWire is one of more than 75 brands within the Dynamic Brand Portfolio at IBN, which provides services including wire solutions via InvestorWire, editorial syndication to 5,000+ outlets, press release enhancement, social media distribution, and corporate communications solutions. For full terms of use and disclaimers applicable to all content provided by NetworkNewsWire, visit https://www.NetworkNewsWire.com/Disclaimer.
